The most frequently mutated gene was TP53 (46%), followed by KRAS (44%), APC (32%), PIK3CA (24%), SMAD4 (14%), FBXW7 (10%), and NRAS (6%), all of which accounted for 88% of CRC patients. The gene discussed is KRAS; the disease is colorectal carcinoma.